| Dr Matthew L Sarb, DO | |
|
127 Crestview Park Dr Ste 204, Dickson, TN 37055-2856 | |
| (615) 441-4545 | |
| (615) 441-4505 |
| Full Name | Dr Matthew L Sarb |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 17 Years |
| Location | 127 Crestview Park Dr Ste 204, Dickson, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407045230 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 3012 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health | Nashville, TN | Home health agency |
| Tristar Horizon Medical Center | Dickson, TN | Hospital |
| Three Rivers Hospital | Waverly, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dickson Medical Associates, Pc | 3971408774 | 53 |
| Select Physical Therapy Holdings Inc | 9537076401 | 1487 |
News Archive
As high schoolers prepare for final exams, teens nationwide may be tempted to use a "study drug" - a prescription stimulant or amphetamine - to gain an academic edge. But a new University of Michigan poll shows only one in 100 parents of teens 13-17 years old believes that their teen has used a study drug.
Researchers have projected that aggressively lowering blood pressure could help prevent more than 100,000 deaths in the U.S. each year.
Interleukin Genetics, Inc. announced today that the Company has signed an agreement with the University of Michigan to conduct a landmark clinical study on risk factors predictive of periodontal disease progression to tooth loss using a new version of Interleukin Genetics' PST genetic test.
A new study from the Journal of Marital & Family Therapy warns of the dramatic rise in the use of psychotropic medications for children. One in every fifty Americans is now considered permanently disabled by mental illness, and up to eight million children take one or more psychotropic drugs.
Biogen Idec and Swedish Orphan Biovitrum today announced that they have restructured the collaboration agreement for the companies' long-acting, recombinant Factor VIII Fc fusion protein (rFVIIIFc) in hemophilia A patients and the recombinant Factor IX Fc fusion protein (rFIXFc) in hemophilia B patients.
› Verified 2 days ago
| Entity Name | Dickson Medical Associates, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568464873 PECOS PAC ID: 3971408774 Enrollment ID: O20031204000828 |
News Archive
As high schoolers prepare for final exams, teens nationwide may be tempted to use a "study drug" - a prescription stimulant or amphetamine - to gain an academic edge. But a new University of Michigan poll shows only one in 100 parents of teens 13-17 years old believes that their teen has used a study drug.
Researchers have projected that aggressively lowering blood pressure could help prevent more than 100,000 deaths in the U.S. each year.
Interleukin Genetics, Inc. announced today that the Company has signed an agreement with the University of Michigan to conduct a landmark clinical study on risk factors predictive of periodontal disease progression to tooth loss using a new version of Interleukin Genetics' PST genetic test.
A new study from the Journal of Marital & Family Therapy warns of the dramatic rise in the use of psychotropic medications for children. One in every fifty Americans is now considered permanently disabled by mental illness, and up to eight million children take one or more psychotropic drugs.
Biogen Idec and Swedish Orphan Biovitrum today announced that they have restructured the collaboration agreement for the companies' long-acting, recombinant Factor VIII Fc fusion protein (rFVIIIFc) in hemophilia A patients and the recombinant Factor IX Fc fusion protein (rFIXFc) in hemophilia B patients.
› Verified 2 days ago
| Entity Name | Premier Orthopaedics & Sports Medicine Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972577351 PECOS PAC ID: 9032023320 Enrollment ID: O20040301001152 |
News Archive
As high schoolers prepare for final exams, teens nationwide may be tempted to use a "study drug" - a prescription stimulant or amphetamine - to gain an academic edge. But a new University of Michigan poll shows only one in 100 parents of teens 13-17 years old believes that their teen has used a study drug.
Researchers have projected that aggressively lowering blood pressure could help prevent more than 100,000 deaths in the U.S. each year.
Interleukin Genetics, Inc. announced today that the Company has signed an agreement with the University of Michigan to conduct a landmark clinical study on risk factors predictive of periodontal disease progression to tooth loss using a new version of Interleukin Genetics' PST genetic test.
A new study from the Journal of Marital & Family Therapy warns of the dramatic rise in the use of psychotropic medications for children. One in every fifty Americans is now considered permanently disabled by mental illness, and up to eight million children take one or more psychotropic drugs.
Biogen Idec and Swedish Orphan Biovitrum today announced that they have restructured the collaboration agreement for the companies' long-acting, recombinant Factor VIII Fc fusion protein (rFVIIIFc) in hemophilia A patients and the recombinant Factor IX Fc fusion protein (rFIXFc) in hemophilia B patients.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew L Sarb, DO 127 Crestview Park Dr Ste 209, Dickson, TN 37055-2856 Ph: (615) 446-5121 | Dr Matthew L Sarb, DO 127 Crestview Park Dr Ste 204, Dickson, TN 37055-2856 Ph: (615) 441-4545 |
News Archive
As high schoolers prepare for final exams, teens nationwide may be tempted to use a "study drug" - a prescription stimulant or amphetamine - to gain an academic edge. But a new University of Michigan poll shows only one in 100 parents of teens 13-17 years old believes that their teen has used a study drug.
Researchers have projected that aggressively lowering blood pressure could help prevent more than 100,000 deaths in the U.S. each year.
Interleukin Genetics, Inc. announced today that the Company has signed an agreement with the University of Michigan to conduct a landmark clinical study on risk factors predictive of periodontal disease progression to tooth loss using a new version of Interleukin Genetics' PST genetic test.
A new study from the Journal of Marital & Family Therapy warns of the dramatic rise in the use of psychotropic medications for children. One in every fifty Americans is now considered permanently disabled by mental illness, and up to eight million children take one or more psychotropic drugs.
Biogen Idec and Swedish Orphan Biovitrum today announced that they have restructured the collaboration agreement for the companies' long-acting, recombinant Factor VIII Fc fusion protein (rFVIIIFc) in hemophilia A patients and the recombinant Factor IX Fc fusion protein (rFIXFc) in hemophilia B patients.
› Verified 2 days ago
Anthony Lynn Tropeano, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 127 Crestview Park Dr Ste 206, Dickson, TN 37055 Phone: 615-441-4522 Fax: 615-441-4523 | |
Dr. John David Tullos, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 127 Crestview Park Dr Ste 204, Dickson, TN 37055 Phone: 615-441-4545 Fax: 615-441-4505 | |
Dr. Juan S Dinkins, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 127 Crestview Park Dr, Dickson, TN 37055 Phone: 615-441-4510 Fax: 615-446-1357 | |
Dr. Brandon Howard Downs, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 415 Henslee Dr, Dickson, TN 37055 Phone: 615-375-8287 Fax: 615-375-8315 |